Actively Recruiting
Evaluating Low-dose Intrathecal Morphine for Pain Relief After Planned Caesarean Section A Randomized, Placebo-Controlled Trial
Led by Anne Juul Wikkelsø · Updated on 2026-09-11
1312
Participants Needed
9
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating whether adding low-dose intrathecal morphine to spinal anaesthesia can improve postoperative pain control for patients undergoing planned caesarean section, while monitoring safety for both mother and baby. This is a randomized, blinded, placebo-controlled multicenter trial aiming to balance pain relief benefits against potential risks. Participants receive a single spinal anaesthesia dose containing either 80 micrograms of preservative-free morphine or a placebo sodium chloride, combined with standard drugs bupivacaine and fentanyl. All participants will also get standard postoperative pain treatment, including morphine tablets as needed, ensuring consistent care across groups. The study will include planned substudies on respiratory monitoring and subgroup analysis. During the study, researchers will collect data from medical records and ask participants to complete questionnaires about pain levels and side effects at multiple time points within 24 hours post-surgery. They will monitor serious adverse events for mother and baby up to 7 days after discharge, and assess longer-term outcomes like breastfeeding at 30 days. The trial is designed to provide detailed information on pain relief effectiveness and safety over the postoperative period.
CONDITIONS
Brief Title
Efficacy and Safety of Intrathecal Morphine for Postoperative Pain Management Following Planned Caesarean Section
Research Team
A
Anneline B Seegert, MD
A
Anne J Wikkelsø, MD, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here